Cholera Vaccine Market - Forecast(2021 - 2026)

Report Code: HCR 84690 Report Format: PDF + Excel (Delivery in 48 Hrs)

Cholera Vaccine Market Overview

Cholera Vaccine market size is forecast to reach $239.6 million by 2026, growing at a CAGR of 7.9% during the forecast period 2021-2026. Cholera is caused via the consumption of contaminated food and water by Vibrio Cholerae. It leads to dehydration which in turn may lead to death if not attended properly. It is anticipated to be a global threat to public health that lacks social development and so it is essential to control cholera. Various products that are used for controlling cholera includes Dukoral, Euvichol, Vaxchora, and Shanchol among others. According to international organizations such as WHO, vaccinations have proved to be one of the best methods to treat cholera and has recommended that cholera vaccines should be taken at least 2 weeks gap between the doses. Rising prevalence of chronic diseases and growing awareness on immunization are the major factors driving the growth of the market. Increasing focus of the key pharmaceutical players to develop vaccines and rising government focus on immunization programs is set to further enhance the overall market development of the Cholera Vaccine Market for the period 2021-2026.

Report Coverage

The report:Cholera Vaccine Market Forecast (2021-2026)”, by Industry ARC, covers an in-depth analysis of the following segments of the Cholera Vaccine Market.
By Product: Dukoral, Shanchol, Vaxchora, Euvichol, and Others.
By End User: Hospitals & Clinics, Research & Academic Laboratories, and Others.
By Geography: North America (U.S., Canada, Mexico), Europe (Germany, United Kingdom (U.K.), France, Italy, Spain, Russia, and Rest of Europe), Asia Pacific (China, Japan India, South Korea, Australia, and New Zealand, and Rest of Asia Pacific), South America (Brazil, Argentina, and Rest of South America), and Rest of the World (Middle East, and Africa).

Key Takeaways

  • Asia-Pacific dominated the Cholera Vaccine Market in 2020 owing to the increase in the prevalence of cholera disease and rise in the awareness of immunization. The Cholera Vaccine Market scope for different regions will be provided in the final report.
  • Favorable medical reimbursement policies and growing adoption of combination vaccines in prevention strategies by government are likely to aid the market growth of the Cholera Vaccine Market report.
  • Detailed analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Cholera Vaccine Market report.
  • Lack of proper sanitation and high cost associated with the development of vaccines is poised to create the hurdles for the Cholera Vaccine Market.

Cholera Vaccine Market Revenue Share, By Geography, 2020(%)

For More Details on This Report - Request for Sample

Cholera Vaccine Market Segment Analysis – By Product Type

Dukoral held the largest share in the Cholera Vaccine Market in 2020 and is estimated to grow at a CAGR 7.3% during the forecast period 2021-2026. This is attributed to the established stockpile by WHO and it is the only vaccine that provides protection caused by heat toxin producing E. coli. Dukoral offers benefits such as minimum adverse effects and single dose live attenuated immunization. FDA approved single dose Vaxchora that is indicated for use in adult and is carried out in U.S. and Australia where 90% of adults vaccinated and developed antibodies that provides immunity against the disease. Vaxchora is estimated to register the highest CAGR over the period 2021-2026.

Cholera Vaccine Market Segment Analysis – By End Users

Hospital held the largest share in the Cholera Vaccine Market in 2020 and is estimated to grow at a CAGR 8.1% during the forecast period 2021-2026. This is attributed to the fact that it offers minimally invasive procedures for cholera along with the high end technological products. Growing demand for immunization, availability of highly skilled and qualified medical professionals in the hospitals along with the rising incidences of cholera is increasing the demand of the hospitals. Favorable reimbursement policies for hospital procedures and improvements in healthcare facilities are increasing the demand of cholera vaccines in hospitals. Hospitals are estimated to register the highest CAGR over the period 2021-2026.

Cholera Vaccine Market Segment Analysis – By Geography

Asia Pacific dominated the Cholera Vaccine Market with a major share of 36.5% in 2020. This is attributed to the rising incidences of cholera and rising awareness about immunization. Growing healthcare expenditures, favorable reimbursement policies, and presence of key players is also increasing the growth of the market in this region. However, North America is estimated to grow at a higher CAGR during the forecast period 2021-2026 owing to the lack of proper sanitation and consumption of contaminated food. Rising government focus on immunization programs and growing awareness about immunization is also increasing the growth of the market in this region.

Cholera Vaccine Market Drivers

Increasing Prevalence of Cholera Disease

Increasing prevalence of chronic disease is expanding the growth of the Cholera Vaccines Market. Cholera is an infectious disease which is caused by eating food or drinking water that is contaminated with bacterium, Vibrio Cholerae. It affects both children and adults and potentially infect other people. The transmission of cholera is linked to inadequate access to clean water and sanitation facilities. According to WHO, there are almost 1.5 to 5 million cases of cholera. Thus, increasing the growth of the Cholera Vaccine Market during the forecast period 2021-2026.

Rise in awareness of immunization

Rise in awareness of immunization is increasing the growth of the Cholera Vaccines Market. A single dose live oral cholera vaccine Vaxchora is approved for adults. Major advance in reducing cholera is that the oral rehydration therapy which is highly effective treatment and it led to a shift in interest away from injected vaccines. The cholera vaccine works by exposing a little dose of live cholera bacteria that causes the body to develop immunity to the diseases and cannot treat a lively infection that has already developed in the body. Thus, increasing the growth of the Cholera Vaccine Market during the forecast period 2021-2026.

Cholera Vaccine Market Challenges

Lack of Proper Sanitation and High Cost Associated with the Development of Vaccines

Some of the factors that are set to impede the growth of the Cholera Vaccine Market are lack of proper sanitation and high cost associated with the development of vaccines. Risk of adverse effects along with the time taken for regulatory approval is also set to hinder the growth of the market.

Cholera Vaccines Market Landscape

Product launches, mergers and acquisitions, joint ventures, and R&D activities are key strategies adopted by players in the Cholera Vaccines Market. In 2020, the Cholera Vaccines Market share is consolidated by the top ten players present in the market. The Cholera Vaccines Market, top 10 companies are Valneva SE, Sanofi, Johnson & Johnson, Celldex Therapeutics Inc., Merck & Co., GlaxoSmithKline Plc., Emergent BioSolutions Inc., and Astellas Pharma Inc. among others.

Relevant reports:

Report Code: HCR 0058

Report Code: HCR 0591

For more Lifesciences and Healthcare related reports, please click here

1. Cholera Vaccine Market- Overview
    1.1 Definitions and Scope
2. Cholera Vaccine Market- Executive Summary
    2.1 Market Revenue and Key Trends by Company
    2.2 Key trends by Product
    2.3 Key trends by End Users
    2.4 Key trends by Geography
3. Cholera Vaccine Market– Comparative Analysis
    3.1 Product Benchmarking – Key Companies
    3.2 Financial Analysis – Key Companies
    3.3 Market Value Split by Key Companies
    3.4 Patent Analysis – Key Companies
    3.5 Pricing Analysis
4. Cholera Vaccine Market- Startup Companies Scenario Premium
    4.1 Key Startup Company Analysis by
        4.1.1 Investment
        4.1.2 Revenue
        4.1.3 Venture Capital and Funding Scenario
5. Cholera Vaccine Market– Industry Market Entry Scenario Premium Premium
    5.1 Regulatory Framework Overview
    5.2 New Business and Ease of Doing business index
    5.3 Case Studies of Successful Ventures
6. Cholera Vaccine Market Forces
    6.1 Market Drivers
    6.2 Market Constraints/Challenges
    6.3 Porters five force model
        6.3.1 Bargaining power of suppliers
        6.3.2 Bargaining powers of customers
        6.3.3 Threat of new entrants
        6.3.4 Rivalry among existing players
        6.3.5 Threat of substitutes
7. Cholera Vaccine Market– Strategic Analysis
    7.1 Value Chain Analysis
    7.2 Opportunities Analysis
    7.3 Market Life Cycle
8. Cholera Vaccine Market– By Product(Market Size –$Million/$Billion)
    8.1 Dukoral
    8.2 Shanchol
    8.3 Vaxchora
    8.4 Euvichol
    8.5 Others
9. Cholera Vaccine Market– By End Users (Market Size –$Million/$Billion)
    9.1 Hospitals & Clinics
    9.2 Research & Academic Laboratories
    9.3 Others
10. Cholera Vaccine Market- By Geography(Market Size –$Million/$Billion)
    10.1 North America
        10.1.1 U.S.
        10.1.2 Mexico
        10.1.3 Canada
    10.2 Europe
        10.2.1 U.K.
        10.2.2 France
        10.2.3 Germany
        10.2.4 Italy
        10.2.5 Spain
        10.2.6 Russia
        10.2.7 Rest of Europe
    10.3 Asia Pacific
        10.3.1 China
        10.3.2 India
        10.3.3 Japan
        10.3.4 South Korea
        10.3.5 Australia & New Zealand
        10.3.6 Rest of Asia Pacific
    10.4 South America
        10.4.1 Brazil
        10.4.2 Argentina
        10.4.3 Rest of South America
    10.5 Rest of the World
        10.5.1 Middle East
        10.5.2 Africa
11. Cholera Vaccine Market- Entropy
12. Cholera Vaccine Market– Industry/Segment Competition Landscape Premium
    12.1 Market Share Analysis
        12.1.1 Global Market Share – Key Companies
        12.1.2 Market Share by Region – Key companies
        12.1.3 Market Share by Countries – Key Companies
        12.1.4 Best Practices for Companies
13. Cholera Vaccine Market– Key Company List by Country Premium Premium
14. Cholera Vaccine Market Company Analysis
    14.1 Company 1
    14.2 Company 2
    14.3 Company 3
    14.4 Company 4
    14.5 Company 5
    14.6 Company 6
    14.7 Company 7
    14.8 Company 8
    14.9 Company 9
    14.10 Company 10
"*Financials for private companies would be provided on a best efforts basis”.

LIST OF TABLES

1.Global CHOLERA VACCINE MARKET, BY PRODUCT Market 2019-2024 ($M)
1.1 Dukoral Market 2019-2024 ($M) - Global Industry Research
1.2 Shanchol Market 2019-2024 ($M) - Global Industry Research
1.3 Vaxchora Market 2019-2024 ($M) - Global Industry Research
1.4 Euvichol Euvichol-Plus Market 2019-2024 ($M) - Global Industry Research
2.Global CHOLERA VACCINE MARKET, BY END USER Market 2019-2024 ($M)
2.1 Hospitals Clinics Market 2019-2024 ($M) - Global Industry Research
2.2 Research Academic Laboratories Market 2019-2024 ($M) - Global Industry Research
3.Global CHOLERA VACCINE MARKET, BY PRODUCT Market 2019-2024 (Volume/Units)
3.1 Dukoral Market 2019-2024 (Volume/Units) - Global Industry Research
3.2 Shanchol Market 2019-2024 (Volume/Units) - Global Industry Research
3.3 Vaxchora Market 2019-2024 (Volume/Units) - Global Industry Research
3.4 Euvichol Euvichol-Plus Market 2019-2024 (Volume/Units) - Global Industry Research
4.Global CHOLERA VACCINE MARKET, BY END USER Market 2019-2024 (Volume/Units)
4.1 Hospitals Clinics Market 2019-2024 (Volume/Units) - Global Industry Research
4.2 Research Academic Laboratories Market 2019-2024 (Volume/Units) - Global Industry Research
5.North America CHOLERA VACCINE MARKET, BY PRODUCT Market 2019-2024 ($M)
5.1 Dukoral Market 2019-2024 ($M) - Regional Industry Research
5.2 Shanchol Market 2019-2024 ($M) - Regional Industry Research
5.3 Vaxchora Market 2019-2024 ($M) - Regional Industry Research
5.4 Euvichol Euvichol-Plus Market 2019-2024 ($M) - Regional Industry Research
6.North America CHOLERA VACCINE MARKET, BY END USER Market 2019-2024 ($M)
6.1 Hospitals Clinics Market 2019-2024 ($M) - Regional Industry Research
6.2 Research Academic Laboratories Market 2019-2024 ($M) - Regional Industry Research
7.South America CHOLERA VACCINE MARKET, BY PRODUCT Market 2019-2024 ($M)
7.1 Dukoral Market 2019-2024 ($M) - Regional Industry Research
7.2 Shanchol Market 2019-2024 ($M) - Regional Industry Research
7.3 Vaxchora Market 2019-2024 ($M) - Regional Industry Research
7.4 Euvichol Euvichol-Plus Market 2019-2024 ($M) - Regional Industry Research
8.South America CHOLERA VACCINE MARKET, BY END USER Market 2019-2024 ($M)
8.1 Hospitals Clinics Market 2019-2024 ($M) - Regional Industry Research
8.2 Research Academic Laboratories Market 2019-2024 ($M) - Regional Industry Research
9.Europe CHOLERA VACCINE MARKET, BY PRODUCT Market 2019-2024 ($M)
9.1 Dukoral Market 2019-2024 ($M) - Regional Industry Research
9.2 Shanchol Market 2019-2024 ($M) - Regional Industry Research
9.3 Vaxchora Market 2019-2024 ($M) - Regional Industry Research
9.4 Euvichol Euvichol-Plus Market 2019-2024 ($M) - Regional Industry Research
10.Europe CHOLERA VACCINE MARKET, BY END USER Market 2019-2024 ($M)
10.1 Hospitals Clinics Market 2019-2024 ($M) - Regional Industry Research
10.2 Research Academic Laboratories Market 2019-2024 ($M) - Regional Industry Research
11.APAC CHOLERA VACCINE MARKET, BY PRODUCT Market 2019-2024 ($M)
11.1 Dukoral Market 2019-2024 ($M) - Regional Industry Research
11.2 Shanchol Market 2019-2024 ($M) - Regional Industry Research
11.3 Vaxchora Market 2019-2024 ($M) - Regional Industry Research
11.4 Euvichol Euvichol-Plus Market 2019-2024 ($M) - Regional Industry Research
12.APAC CHOLERA VACCINE MARKET, BY END USER Market 2019-2024 ($M)
12.1 Hospitals Clinics Market 2019-2024 ($M) - Regional Industry Research
12.2 Research Academic Laboratories Market 2019-2024 ($M) - Regional Industry Research
13.MENA CHOLERA VACCINE MARKET, BY PRODUCT Market 2019-2024 ($M)
13.1 Dukoral Market 2019-2024 ($M) - Regional Industry Research
13.2 Shanchol Market 2019-2024 ($M) - Regional Industry Research
13.3 Vaxchora Market 2019-2024 ($M) - Regional Industry Research
13.4 Euvichol Euvichol-Plus Market 2019-2024 ($M) - Regional Industry Research
14.MENA CHOLERA VACCINE MARKET, BY END USER Market 2019-2024 ($M)
14.1 Hospitals Clinics Market 2019-2024 ($M) - Regional Industry Research
14.2 Research Academic Laboratories Market 2019-2024 ($M) - Regional Industry Research

LIST OF FIGURES

1.US Cholera Vaccine Market Revenue, 2019-2024 ($M)
2.Canada Cholera Vaccine Market Revenue, 2019-2024 ($M)
3.Mexico Cholera Vaccine Market Revenue, 2019-2024 ($M)
4.Brazil Cholera Vaccine Market Revenue, 2019-2024 ($M)
5.Argentina Cholera Vaccine Market Revenue, 2019-2024 ($M)
6.Peru Cholera Vaccine Market Revenue, 2019-2024 ($M)
7.Colombia Cholera Vaccine Market Revenue, 2019-2024 ($M)
8.Chile Cholera Vaccine Market Revenue, 2019-2024 ($M)
9.Rest of South America Cholera Vaccine Market Revenue, 2019-2024 ($M)
10.UK Cholera Vaccine Market Revenue, 2019-2024 ($M)
11.Germany Cholera Vaccine Market Revenue, 2019-2024 ($M)
12.France Cholera Vaccine Market Revenue, 2019-2024 ($M)
13.Italy Cholera Vaccine Market Revenue, 2019-2024 ($M)
14.Spain Cholera Vaccine Market Revenue, 2019-2024 ($M)
15.Rest of Europe Cholera Vaccine Market Revenue, 2019-2024 ($M)
16.China Cholera Vaccine Market Revenue, 2019-2024 ($M)
17.India Cholera Vaccine Market Revenue, 2019-2024 ($M)
18.Japan Cholera Vaccine Market Revenue, 2019-2024 ($M)
19.South Korea Cholera Vaccine Market Revenue, 2019-2024 ($M)
20.South Africa Cholera Vaccine Market Revenue, 2019-2024 ($M)
21.North America Cholera Vaccine By Application
22.South America Cholera Vaccine By Application
23.Europe Cholera Vaccine By Application
24.APAC Cholera Vaccine By Application
25.MENA Cholera Vaccine By Application
26.Astellas Pharma, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
27.Celldex Therapeutics, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
28.Emergent BioSolutions, Inc., Sales /Revenue, 2015-2018 ($Mn/$Bn)
29.Eubiologics Co., Ltd., Sales /Revenue, 2015-2018 ($Mn/$Bn)
30.Johnson Johnson, Sales /Revenue, 2015-2018 ($Mn/$Bn)
31.Sanofi, Sales /Revenue, 2015-2018 ($Mn/$Bn)